Skip to main
CTRE
CTRE logo

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 39%
Hold 28%
Sell 6%
Strong Sell 0%

Bulls say

CareTrust REIT Inc. is poised for growth, with expectations to increase its estimated net asset value (NAV) from $21.62 per share in 2025 to $24.05 per share by the end of 2026, indicating a positive trajectory in the company's valuation. The management team is nearing the conclusion of its portfolio optimization plan, which, along with a recovering core portfolio and robust corporate guarantees on leases, suggests a strong foundation for future growth. Additionally, the recent $817 million acquisition of UK-based Care REIT reflects an opportunity for immediate value enhancement and positions CareTrust favorably within an improved competitive landscape for capital deployment.

Bears say

CareTrust REIT is facing a negative outlook primarily due to a lower growth forecast, which is expected to result in a decline in cash collections by approximately 5% and a notable slowdown in investment activity, projected to fall to around $500 million. Furthermore, potential legislative changes, such as the CA 525 bill, threaten operators' profitability in California, which could exert additional pressure on CareTrust's rental income. Additionally, ongoing issues with tenants and a tightening reimbursement environment, particularly from Medicaid cuts, raise concerns about the company's earnings growth and overall financial stability.

CareTrust REIT (CTRE) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 39% recommend Buy, 28% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 18 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.